{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:54:57Z","timestamp":1791417297867,"version":"4.3.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T00:00:00Z","timestamp":1528934400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007181","name":"Biotechnology Research Center, Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["1395.06.27"],"award-info":[{"award-number":["1395.06.27"]}],"id":[{"id":"10.13039\/501100007181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["1400.88.51"],"award-info":[{"award-number":["1400.88.51"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s13105-018-0640-2","type":"journal-article","created":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T02:27:31Z","timestamp":1528943251000},"page":"467-478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["FPS-ZM1 and valsartan combination protects better against glomerular filtration barrier damage in streptozotocin-induced diabetic rats"],"prefix":"10.1007","volume":"74","author":[{"given":"Davoud","family":"Sanajou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9653-0302","authenticated-orcid":false,"given":"Amir","family":"Ghorbani Haghjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Argani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Roshangar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed Nazari Soltan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra Ashrafi","family":"Jigheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Aslani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Panah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalil","family":"Rashedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Mesgari Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,14]]},"reference":[{"issue":"39","key":"640_CR1","doi-asserted-by":"publisher","first-page":"30716","DOI":"10.1074\/jbc.M004569200","volume":"275","author":"A Boutaud","year":"2000","unstructured":"Boutaud A, Borza D-B, Bondar O, Gunwar S, Netzer K-O, Singh N, Ninomiya Y, Sado Y, Noelken ME, Hudson BG (2000) Type IV collagen of the glomerular basement membrane evidence that the chain specificity of network assembly is encoded by the noncollagenous nc1 domains. J Biol Chem 275(39):30716\u201330724","journal-title":"J Biol Chem"},{"issue":"1","key":"640_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1586\/eem.09.70","volume":"5","author":"FC Brosius","year":"2010","unstructured":"Brosius FC, Khoury CC, Buller CL, Chen S (2010) Abnormalities in signaling pathways in diabetic nephropathy. Expert Rev Endocrinol Metab 5(1):51\u201364","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"318","key":"640_CR3","first-page":"1315","volume":"1988","author":"M Brownlee","year":"1988","unstructured":"Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988(318):1315\u20131321","journal-title":"N Engl J Med"},{"key":"640_CR4","first-page":"18225","volume":"8","author":"S Chen","year":"2015","unstructured":"Chen S, Chen H, Liu Q, Ma Q (2015) Effect of simvastatin on the expression of nephrin, podocin, and vascular endothelial growth factor (VEGF) in podocytes of diabetic rat. Int J Clin Exp Med 8:18225\u201318234","journal-title":"Int J Clin Exp Med"},{"issue":"5","key":"640_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1053\/snep.2002.34724","volume":"22","author":"ME Cooper","year":"2002","unstructured":"Cooper ME, Mundel P, Boner G (2002) Role of nephrin in renal disease including diabetic nephropathy. Semin Nephrol 22(5):393\u2013398","journal-title":"Semin Nephrol"},{"issue":"8","key":"640_CR6","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1681\/ASN.2006010033","volume":"17","author":"C Dai","year":"2006","unstructured":"Dai C, Stolz DB, Bastacky SI, Arnaud RS, Wu C, Dedhar S, Liu Y (2006) Essential role of integrin-linked kinase in podocyte biology: bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol 17(8):2164\u20132175","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"640_CR7","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1172\/JCI58642","volume":"122","author":"R Deane","year":"2012","unstructured":"Deane R, Singh I, Sagare AP, Bell RD, Ross NT, LaRue B, Love R, Perry S, Paquette N, Deane RJ (2012) A multimodal RAGE-specific inhibitor reduces amyloid \u03b2-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest 122(4):1377\u20131392","journal-title":"J Clin Invest"},{"issue":"5","key":"640_CR8","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3892\/etm.2012.680","volume":"4","author":"D Fang","year":"2012","unstructured":"Fang D, Wan X, Deng W, Guan H, Ke W, Xiao H, Li Y (2012) Fufang Xue Shuan Tong capsules inhibit renal oxidative stress markers and indices of nephropathy in diabetic rats. Exp Ther Med 4(5):871\u2013876","journal-title":"Exp Ther Med"},{"issue":"8","key":"640_CR9","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1007\/s00125-003-1162-0","volume":"46","author":"J Figarola","year":"2003","unstructured":"Figarola J, Scott S, Loera S, Tessler C, Chu P, Weiss L, Hardy J, Rahbar S (2003) LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats. Diabetologia 46(8):1140\u20131152","journal-title":"Diabetologia"},{"issue":"5","key":"640_CR10","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s00125-008-0935-x","volume":"51","author":"J Figarola","year":"2008","unstructured":"Figarola J, Loera S, Weng Y, Shanmugam N, Natarajan R, Rahbar S (2008) LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat. Diabetologia 51(5):882\u2013891","journal-title":"Diabetologia"},{"issue":"1","key":"640_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2337\/diabetes.53.1.166","volume":"53","author":"A Flyvbjerg","year":"2004","unstructured":"Flyvbjerg A, Denner L, Schrijvers BF, Tilton RG, Mogensen TH, Paludan SR, Rasch R (2004) Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice. Diabetes 53(1):166\u2013172","journal-title":"Diabetes"},{"issue":"2","key":"640_CR12","first-page":"28","volume":"4","author":"SB Ghaderian","year":"2015","unstructured":"Ghaderian SB, Hayati F, Shayanpour S, Mousavi SSB (2015) Diabetes and end-stage renal disease; a review article on new concepts. J Renal Inj Prev 4(2):28\u201333","journal-title":"J Renal Inj Prev"},{"key":"640_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4626125","volume":"2016","author":"C Gluhovschi","year":"2016","unstructured":"Gluhovschi C, Gluhovschi G, Petrica L, Timar R, Velciov S, Ionita I, Kaycsa A, Timar B (2016) Urinary biomarkers in the assessment of early diabetic nephropathy. J Diabetes Res 2016:1\u201313","journal-title":"J Diabetes Res"},{"issue":"5","key":"640_CR14","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1681\/ASN.2007101109","volume":"19","author":"J Guo","year":"2008","unstructured":"Guo J, Ananthakrishnan R, Qu W, Lu Y, Reiniger N, Zeng S, Ma W, Rosario R, Yan SF, Ramasamy R (2008) RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis. J Am Soc Nephrol 19(5):961\u2013972","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"640_CR15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000477946","volume":"42","author":"F-Y Hsu","year":"2017","unstructured":"Hsu F-Y, Lin F-J, Ou H-T, Huang S-H, Wang C-C (2017) Renoprotective effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic patients with proteinuria. Kidney Blood Press Res 42(2):358\u2013368","journal-title":"Kidney Blood Press Res"},{"issue":"5","key":"640_CR16","doi-asserted-by":"publisher","first-page":"e36041","DOI":"10.1371\/journal.pone.0036041","volume":"7","author":"B Jim","year":"2012","unstructured":"Jim B, Ghanta M, Qipo A, Fan Y, Chuang PY, Cohen HW, Abadi M, Thomas DB, He JC (2012) Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study. PLoS One 7(5):e36041","journal-title":"PLoS One"},{"key":"640_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejphar.2015.04.055","volume":"761","author":"E Jung","year":"2015","unstructured":"Jung E, Kim J, Kim SH, Kim S, Cho M-H (2015) Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy. Eur J Pharmacol 761:116\u2013124","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"640_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7326\/0003-4819-148-1-200801010-00190","volume":"148","author":"R Kunz","year":"2008","unstructured":"Kunz R, Friedrich C, Wolbers M, Mann JF (2008) Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin\u2013angiotensin system on proteinuria in renal disease. Ann Intern Med 148(1):30\u201348","journal-title":"Ann Intern Med"},{"issue":"5","key":"640_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11892-016-0735-5","volume":"16","author":"JS Lin","year":"2016","unstructured":"Lin JS, Susztak K (2016) Podocytes: the weakest link in diabetic kidney disease? Curr Diab Rep 16(5):45","journal-title":"Curr Diab Rep"},{"issue":"1","key":"640_CR20","doi-asserted-by":"publisher","first-page":"F46","DOI":"10.1152\/ajprenal.00184.2016","volume":"311","author":"SK Mallipattu","year":"2016","unstructured":"Mallipattu SK, He JC (2016) The podocyte as a direct target for treatment of glomerular disease? Am J Physiol Ren Physiol 311(1):F46\u2013F51","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"640_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12913-015-1166-8","volume":"15","author":"L Mushi","year":"2015","unstructured":"Mushi L, Marschall P, Fle\u00dfa S (2015) The cost of dialysis in low and middle-income countries: a systematic review. BMC Health Serv Res 15(1):506","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"640_CR22","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2337\/diab.46.5.895","volume":"46","author":"S Nakamura","year":"1997","unstructured":"Nakamura S, Makita Z, Ishikawa S, Yasumura K, Fujii W, Yanagisawa K, Kawata T, Koike T (1997) Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes 46(5):895\u2013899","journal-title":"Diabetes"},{"issue":"1","key":"640_CR23","doi-asserted-by":"publisher","first-page":"e0147329","DOI":"10.1371\/journal.pone.0147329","volume":"11","author":"M Narres","year":"2016","unstructured":"Narres M, Claessen H, Droste S, Kvitkina T, Koch M, Kuss O, Icks A (2016) The incidence of end-stage renal disease in the diabetic (compared to the non-diabetic) population: a systematic review. PLoS One 11(1):e0147329","journal-title":"PLoS One"},{"issue":"2","key":"640_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/ki.2013.387","volume":"85","author":"MA Reddy","year":"2013","unstructured":"Reddy MA, Sumanth P, Lanting L, Yuan H, Wang M, Mar D, Alpers CE, Bomsztyk K, Natarajan R (2013) Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db\/db mice. Kidney Int 85(2):362\u2013373","journal-title":"Kidney Int"},{"issue":"8","key":"640_CR25","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.2337\/db09-1766","volume":"59","author":"N Reiniger","year":"2010","unstructured":"Reiniger N, Lau K, McCalla D, Eby B, Cheng B, Lu Y, Qu W, Quadri N, Ananthakrishnan R, Furmansky M, Rosario R, Song F, Rai V, Weinberg A, Friedman R, Ramasamy R, D\u2019Agati V, Schmidt AM (2010) Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse. Diabetes 59(8):2043\u20132054","journal-title":"Diabetes"},{"issue":"8","key":"640_CR26","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1681\/ASN.2010020218","volume":"21","author":"AB Sanz","year":"2010","unstructured":"Sanz AB, Sanchez-Ni\u00f1o MD, Ramos AM, Moreno JA, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A (2010) NF-\u03baB in renal inflammation. J Am Soc Nephrol 21(8):1254\u20131262","journal-title":"J Am Soc Nephrol"},{"key":"640_CR27","first-page":"02017","volume":"00434","author":"I Sharma","year":"2017","unstructured":"Sharma I, Tupe RS, Wallner AK, Kanwar YS (2017) Contribution of myo-inositol oxygenase in AGE:RAGE-mediated renal tubulointerstitial injury in the context of diabetic nephropathy. Am J Physiol Renal Physiol 00434:02017","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"640_CR28","doi-asserted-by":"publisher","first-page":"F763","DOI":"10.1152\/ajprenal.00591.2009","volume":"298","author":"AL Tan","year":"2010","unstructured":"Tan AL, Sourris KC, Harcourt BE, Thallas-Bonke V, Penfold S, Andrikopoulos S, Thomas MC, O\u2019Brien RC, Bierhaus A, Cooper ME (2010) Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. Am J Physiol Renal Physiol 298(3):F763\u2013F770","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"640_CR29","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.2337\/db11-1546","volume":"61","author":"AM Watson","year":"2012","unstructured":"Watson AM, Gray SP, Jiaze L, Soro-Paavonen A, Wong B, Cooper ME, Bierhaus A, Pickering R, Tikellis C, Tsorotes D (2012) Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice. Diabetes 61(8):2105\u20132113","journal-title":"Diabetes"},{"issue":"4","key":"640_CR30","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S0002-9440(10)63909-0","volume":"162","author":"TM Wendt","year":"2003","unstructured":"Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, Bucciarelli LG, Rong LL, Moser B, Markowitz GS (2003) RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol 162(4):1123\u20131137","journal-title":"Am J Pathol"},{"issue":"11","key":"640_CR31","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.2337\/diabetes.51.11.3283","volume":"51","author":"JL Wilkinson-Berka","year":"2002","unstructured":"Wilkinson-Berka JL, Kelly DJ, Koerner SM, Jaworski K, Davis B, Thallas V, Cooper ME (2002) ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2) 27 rat. Diabetes 51(11):3283\u20133289","journal-title":"Diabetes"},{"key":"640_CR32","doi-asserted-by":"publisher","unstructured":"Xia H, Bao W, Shi S (2017) Innate immune activity in glomerular podocytes. Front Immunol 8(122). \n                    https:\/\/doi.org\/10.3389\/fimmu.2017.00122","DOI":"10.3389\/fimmu.2017.00122"},{"issue":"18","key":"640_CR33","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2174\/1381612054367300","volume":"11","author":"S-i Yamagishi","year":"2005","unstructured":"Yamagishi S-i, Imaizumi T (2005) Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des 11(18):2279\u20132299","journal-title":"Curr Pharm Des"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13105-018-0640-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-018-0640-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-018-0640-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T19:16:56Z","timestamp":1560453416000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13105-018-0640-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,14]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["640"],"URL":"https:\/\/doi.org\/10.1007\/s13105-018-0640-2","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,14]]},"assertion":[{"value":"16 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}